Pro Medicus Limited (PME) To Go Ex-Dividend on February 26th

Pro Medicus Limited (ASX:PME) announced a interim dividend on Friday, February 14th, MarketIndexAU Dividends reports. Shareholders of record on Thursday, March 20th will be paid a dividend of 0.25 per share on Thursday, March 20th. This represents a yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. This is a positive change from Pro Medicus’s previous interim dividend of $0.18.

Pro Medicus Price Performance

The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10. The stock has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56.

Insider Buying and Selling at Pro Medicus

In other news, insider Alice Williams acquired 125 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were purchased at an average cost of A$272.69 ($173.69) per share, with a total value of A$34,086.00 ($21,710.83). Also, insider Sam Hupert sold 1,000,000 shares of Pro Medicus stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of A$256.73 ($163.52), for a total value of A$256,730,000.00 ($163,522,292.99). Insiders own 51.20% of the company’s stock.

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.